Cargando…
Haprolid Inhibits Tumor Growth of Hepatocellular Carcinoma through Rb/E2F and Akt/mTOR Inhibition
Background: Hepatocellular carcinoma (HCC) represents a major health burden with limited curative treatment options. There is a substantial unmet need to develop innovative approaches to impact the progression of advanced HCC. Haprolid is a novel natural component isolated from myxobacteria. Haproli...
Autores principales: | Xing, Jun, Bhuria, Vikas, Bui, Khac Cuong, Nguyen, Mai Ly Thi, Hu, Zexi, Hsieh, Chih-Jen, Wittstein, Kathrin, Stadler, Marc, Wilkens, Ludwig, Li, Jun, Kalesse, Markus, Bozko, Przemyslaw, Plentz, Ruben R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139901/ https://www.ncbi.nlm.nih.gov/pubmed/32155915 http://dx.doi.org/10.3390/cancers12030615 |
Ejemplares similares
-
Gamma‐Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt‐Beta‐Catenin Pathways in CD44(+) Gastric Cancer Stem Cells
por: Barat, Samarpita, et al.
Publicado: (2017) -
Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017) -
Activation of Notch Signaling Is Required for Cholangiocarcinoma Progression and Is Enhanced by Inactivation of p53 In Vivo
por: El Khatib, Mona, et al.
Publicado: (2013) -
Correction: Activation of Notch Signaling Is Required for Cholangiocarcinoma Progression and Is Enhanced by Inactivation of p53 In Vivo
por: El Khatib, Mona, et al.
Publicado: (2018) -
Combined inhibition of PIM and CDK4/6 suppresses both mTOR signaling and Rb phosphorylation and potentiates PI3K inhibition in cancer cells
por: Litchfield, Lacey M., et al.
Publicado: (2020)